Ilana uses chemical biology-based methods to study the regulation and protein-protein interactions of Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

podcast list Strategic Partner(s) Gáspár Pándy-Szekeres About Gáspár Pándy-Szekeres " After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's group as a bioinformatician.

activation mechanism of this family of G protein-coupled receptors using innovative approaches, including biosensors

Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Neuroscience, and Artificial Intelligence and Human Health, as well as the Dean of The Graduate School of Biomedical To this end, her lab uses several computational structural biology tools and rational drug design approaches , ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy in Computational Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics

GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

Yamina's Corner Expert strategic and scientific consultancy for GPCR-focused biotechs, VCs, and CROs. Get Team Access GPCR University Expert-led courses spanning GPCR drug discovery — from receptor biology Corner Timeline Strategy Strategic workshops that replace trial-and-error with proven frameworks for biotech Visibility for Solution Providers Strategic media partnerships that connect your company with biotech Wherever you are in your discovery journey, the Foundry helps GPCR biotech companies move faster and

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. Who We Are We are a global network of scientists, biotech innovators, pharma professionals, CRO leaders & Get Our Weekly News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Now, it's a global ecosystem of scientists, biotech teams, CRO leaders, and trainees working to move Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools

Frequently asked questions Webinar University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology Translational scientists Biotech and pharmaceutical researchers Postdoctoral fellows and graduate researchers The content is highly relevant for biotech and pharmaceutical scientists. These programs are designed for scientists seeking advanced, mechanism-focused training in GPCR biology

GPCRs are among the most powerful and complex targets in biomedical research. Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of Bordeaux and an MS in biomedical business management from the Grenoble School of Management. Internalization is a core—but often overlooked—dimension of GPCR biology.

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

He is Professor of Biochemistry at the Medical College of Wisconsin in Milwaukee.

As a CRO partner, you'll gain trusted access to an engaged audience of biotech teams and drug discovery partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion Engaging posts about your organization targeted to GPCR researchers and biotech

signalling <p class="font_8">Watch Now</p> Sudarshan Rajagopal The Spatiotemporal Revolution in GPCR Biology GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech

tissue-specific engagement Who should listen Navigated complex datasets where interpretation depended on biological His group develops imaging and chemical biology tools to reveal how GLP-1 and GIP receptors operate within David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Unlock

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

not just sequence matches — is non-trivial, and it matters for anyone hoping to translate kidney OR biology She received her undergraduate degree in biology from Truman State University and earned her Ph.D. in laboratory of Michael Caplan at Yale University, where she studied both renal physiology and sensory biology

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before She received her undergraduate degree in Biotechnology from KIIT University in India. Monserrat Avila Zozaya I did a PhD in cell biology at CINVESTAV, Mexico. About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Biology his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical and biotech

underappreciated axis of pharmacological modulation, and long-running collaborations on beta-adrenergic receptor biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

chemists, systems biologists, structural biologists, and drug-discovery veterans — drew on their combined Yaroslav Nikolaev is a scientist at InterAx Biotech with a dual background in biology and computation His research combines biomolecular NMR, structural biology, and machine learning to study how GPCRs function True negatives quietly wreck biological models. The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide

Silvia Sposini " I'm originally from Rome, Italy, where I studied Biological Sciences as a BSc student

Key Takeaways: From Protein Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. Dmitry studied biophysics at the Moscow State University, followed by a PhD (1998) in protein folding He joined the MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology

Claudia Stäubert "I received my degree in biochemistry from Leipzig University (Germany) being already Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn

This conversation covers what it looks like to do receptor biology when you are writing the first chapter She trained in protein biochemistry and neuroscience, completing her PhD in Germany and her postdoctoral Since returning to Europe, her research has centered on receptor biology at the intersection of basic It is a small detail, but it marks something real about the state of adhesion GPCR biology in insects : these receptors exist in a space where the biology precedes the vocabulary.